FluroTech Ltd., a technology company focused on becoming the standard in the analytical cannabis and hemp testing market, announces that it has agreed to release CaryLand LLC from the non-exclusive distribution agreement (“Agreement”) that was announced on December 10, 2019.
Pursuant to the Agreement, CaryLand purchased and paid for three CompleTest™ devices during December 2019. However, due to CaryLand’s internal restructuring, CaryLand is no longer able to fulfill its obligations under the Agreement, and accordingly the parties mutually agreed to the termination of the Agreement. FluroTech is currently engaged in advanced discussions with several other US based distributors.
FluroTech still believes that the ever-evolving Federal Drug Administration regulations represent an exceptional opportunity for the CompleTest™ to be utilized by growers and regulators to distinguish hemp from marijuana. FluroTech believes it is uniquely positioned to capitalize on this opportunity, given the recent advances to FluroTech’s technological capabilities and the accuracy of its testing, which have been independently validated.
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis and hemp industries. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using technology that was first developed at the University of Calgary, FluroTech has created a two-part solution comprising a platform technology called the CompleTest™ and consumable testing kits. Its accuracy has been independently validated. FluroTech continues to develop additional applications for the CompleTest platform technology.
To learn more, visit: www.FluroTech.com